Dosage and administration In patients with type 2 diabetes, monitor blood glucose prior to starting WEGOVY and during WEGOVY treatment [see Warnings and Precautions (5.4 )]
Like the snow cone flavor.* Was this helpful
Adverse Events Across Trials The safety pattern is consistent across the published trials: gastrointestinal events dominate, they are dose-related, mostly mild to moderate, concentrated during dose escalation, and partially mitigated by starting at 2 mg rather than 4 mg
This makes it easier to obtain highquality Sprays items regardless of location
Bacteriostatic water contains a preservative that inhibits microbial growth, extending the usable life of your reconstituted solution to 2-4 weeks when refrigerated
Some participants in clinical trials have reported difficulty falling or staying asleep, particularly in the early weeks of treatment, though whether this reflects a direct drug effect remains uncertain